Skip to content

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Other financials

Income statement

See full
Revenue$367.6M-3.9%
Operating income$4.8M-69.5%
Net income-$3.5M-158%
EPS (diluted)-$0.13-157%

Balance sheet

See full
Cash & equivalents$17.9M-13.0%
Total debt$930.7M+10.9%
Total equity$538.6M-16.7%
Total assets$1.7B-4.2%

Cash flow

See full
Operating cash flow$33.4M-60.4%
CapEx$9.6M-81.8%
Free cash flow$23.8M-24.9%

Valuation

See full
Market cap$401.61M-37.4%
Enterprise value$1.31B-10.0%
P/S0.3×-0.1×

Profitability

See full
Operating margin-4.9%-13.2pp
Net margin-7.1%-11.9pp
FCF margin5.1%

Returns & leverage

See full
Return on equity-18.5%-32.0pp
Debt / equity1.7×+0.4×
Current ratio1.1×-0.1×